&lt;i&gt;SULT&lt;/i&gt; and &lt;i&gt;UGT&lt;/i&gt; Genetic Variants Modulate Side Effect Profiles in South African Breast Cancer Patients Treated with Tamoxifen. This evidence concerns the gene SLC35A2 and breast carcinoma.